ALGS SCHEDULE 13G: SEC filing
Parkman Healthcare Partners LLC and affiliated entities
Filed with the SEC on · accession 0000919574-26-007697
ALGS filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 13, 2026. Parkman Healthcare Partners LLC and affiliated entities filed a Schedule 13G disclosing beneficial ownership of 325,537 shares, or 5.2%, of Aligos Therapeutics common stock as of September 30, 2026. The stock moved +6.1% by the first close after the filing.
Summary of the filing
Parkman Healthcare Partners LLC and affiliated entities filed a Schedule 13G disclosing beneficial ownership of 325,537 shares, or 5.2%, of Aligos Therapeutics common stock as of September 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(b).
Key details
How ALGS stock reacted
Close before
$1.98
Nov 12, 2026
First close after
+6.06%
$2.10
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for ALGS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ALGS?
Click hereFrequently asked questions
What did ALGS file with the SEC on Nov 13, 2026?
ALGS filed a SCHEDULE 13G (SEC filing). Parkman Healthcare Partners LLC and affiliated entities filed a Schedule 13G disclosing beneficial ownership of 325,537 shares, or 5.2%, of Aligos Therapeutics common stock as of September 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(b).
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did ALGS stock react to this filing?
ALGS closed at $1.98 before the filing and $2.10 on Nov 13, 2026 (+6.06%).
Other ALGS SEC filings
Get alerts when ALGS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days